Crossmark

Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury

Crossref DOI link: https://doi.org/10.1186/s12906-025-04886-y

Published Online: 2025-04-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shahsavari, Kasra

Ardekani, Shireen Shams

Ardekani, Mohammad Reza Shams

Esfahani, Majid Mokaber

Kazemizadeh, Hossein

Jamialahmadi, Tannaz

Iranshahi, Mehrdad

Khanavi, Mahnaz https://orcid.org/0000-0001-8392-9795
Hasanpour, Maede https://orcid.org/0000-0002-8260-6123
License Information

Text and Data Mining valid from 2025-04-12

Version of Record valid from 2025-04-12
More Information

Article History

Received: 5 August 2024

Accepted: 4 April 2025

First Online: 12 April 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below